Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds

13D Filing: Waud Capital Partners Ii, L.p. and Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Published on March 21, 2017 at 4:52 pm by Insider Monkey Staff in Hedge Funds

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Waud Capital Partners II 0 570,710 0 570,710 570,710 0.7%
Waud Capital Partners QP II 0 1,043,348 0 1,043,348 1,043,348 1.2%
Halcyon Exempt Family Trust 0 531,113 0 531,113 531,113 0.6%
Waud Family Partners 0 41,765 0 41,765 41,765 0.05%
WCP FIF II (Acadia) 0 159,233 0 159,233 159,233 0.2%
Waud Capital Affiliates II 0 163,082 0 163,082 163,082 0.2%
Waud Capital Affiliates III 0 83,694 0 83,694 83,694 0.1%
WCP FIF III (Acadia) 0 227,335 0 227,335 227,335 0.3%
Waud Capital Partners QP III 0 518,000 0 518,000 518,000 0.6%
Waud Capital Partners III 0 91,602 0 91,602 91,602 0.1%
Waud Capital Partners Management II 0 1,936,373 0 1,936,373 1,936,373 2.2%
Waud Capital Partners II 0 1,936,373 0 1,936,373 1,936,373 2.2%
Waud Capital Partners Management III 0 920,631 0 920,631 920,631 1.1%
Waud Capital Partners III 0 920,631 0 920,631 920,631 1.1%
Waud Capital Partners 0 39,851 0 39,851 39,851 0.05%
Crystal Cove 0 795,667 0 795,667 795,667 0.9%
Reeve B. Waud 0 4,298,733 0 4,298,733 4,298,733 4.9%
Melissa W. Waud 0 33,333 0 33,333 33,333 0.04%

Page 1 of 27 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE
13D/A

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(a)

Under the Securities Exchange Act of 1934

(Amendment No. 5)

Acadia
Healthcare Company, Inc.

(Name of issuer)

Common Stock,
par value $0.01

(Title of class of securities)

00404A109

(CUSIP number)

Waud Capital Partners

300 N. LaSalle St., Suite 4900

Chicago, IL 60654

(312)
676-8400

COPY TO:

Carol
Anne Huff

Kirkland & Ellis LLP

300 N. LaSalle St.

Chicago, Illinois 60654

(312) 862-2000

(Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 15,
2017

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

Note: Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 2 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
2
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners II, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

     0
  (8)

Shared voting power

570,710 (See Item 5)
  (9)

Sole dispositive power

     0
(10)

Shared dispositive power

570,710 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

570,710 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.7% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 3 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
3
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners QP II, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

     0
  (8)

Shared voting power

1,043,348 (See Item 5)
  (9)

Sole dispositive power

     0
(10)

Shared dispositive power

1,043,348 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

1,043,348 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

1.2% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 4 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
4
of 26
  (1) 

Names of
reporting persons

Halcyon Exempt Family Trust
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Illinois

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

     0
  (8)

Shared voting power

531,113 (See Item 5)
  (9)

Sole dispositive power

     0
(10)

Shared dispositive power

531,113 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

531,113 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.6% (See Item 5)
(14)

Type of reporting person (see
instructions)

OO

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 5 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
5
of 26
  (1) 

Names of
reporting persons

Waud Family Partners, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

41,765 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

41,765 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

41,765 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.05% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 6 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
6
of 26
  (1) 

Names of
reporting persons

WCP FIF II (Acadia), L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

159,233 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

159,233 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

159,233 (See Item 4)
(12)

Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (9)

0.2% (See Item 4)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 7 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
7
of 26
  (1) 

Names of
reporting persons

Waud Capital Affiliates II, L.L.C.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

163,082 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

163,082 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

163,082 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.2% (See Item 5)
(14)

Type of reporting person (see
instructions)

OO

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 8 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
8
of 26
  (1) 

Names of
reporting persons

Waud Capital Affiliates III, L.L.C.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

83,694 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

83,694 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

83,694 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.1% (See Item 5)
(14)

Type of reporting person (see
instructions)

OO

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 9 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
9
of 26
  (1) 

Names of
reporting persons

WCP FIF III (Acadia), L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

227,335 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

227,335 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

227,335 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.3% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 10 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
10
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners QP III, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

518,000 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

518,000 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

518,000 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.6% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 11 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
11
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners III, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

91,602 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

91,602 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

91,602 (See Item 5)
(12)

Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (9)

0.1% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 12 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
12
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners Management II, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

1,936,373 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

1,936,373 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

1,936,373 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

2.2% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 13 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
13
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners II, L.L.C.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

1,936,373 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

1,936,373 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

1,936,373 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

2.2% (See Item 5)
(14)

Type of reporting person (see
instructions)

OO

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 14 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
14
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners Management III, L.P.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

920,631 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

920,631 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

920,631 (See Item 5)
(12)

Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (9)

1.1% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 15 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
15
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners III, L.L.C.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

920,631 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

920,631 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

920,631 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

1.1% (See Item 5)
(14)

Type of reporting person (see
instructions)

OO

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 16 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
16
of 26
  (1) 

Names of
reporting persons

Waud Capital Partners, L.L.C.
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

39,851 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

39,851 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

39,851 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.05% (See Item 5)
(14)

Type of reporting person (see
instructions)

OO

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 17 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
17
of 26
  (1) 

Names of
reporting persons

Crystal Cove LP
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

795,667 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

795,667 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

795,667 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.9% (See Item 5)
(14)

Type of reporting person (see
instructions)

PN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 18 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
18
of 26
  (1) 

Names of
reporting persons

Reeve B. Waud
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

OO (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

United States

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

4,298,733 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

4,298,733 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

4,298,733 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

4.9% (See Item 5)
(14)

Type of reporting person (see
instructions)

IN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 19 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
19
of 26
  (1) 

Names of
reporting persons

Melissa W. Waud
  (2)

Check the appropriate box if a member
of a group (see instructions)

(a)  ☐        (b)  ☐
  (3)

SEC use only
  (4)

Source of funds (see instructions)

PF (See Item 3)
  (5)

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐
  (6)

Citizenship or place of
organization

United States

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (7) 

Sole voting power

0
  (8)

Shared voting power

33,333 (See Item 5)
  (9)

Sole dispositive power

0
(10)

Shared dispositive power

33,333 (See Item 5)
(11)

Aggregate amount beneficially owned by each reporting person

33,333 (See Item 5)
(12)

Check if the aggregate amount in Row
(11) excludes certain shares (see instructions)  ☐
(13)

Percent of class represented by amount
in Row (11)

0.04% (See Item 5)
(14)

Type of reporting person (see
instructions)

IN

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 20 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
20
of 26

The Statement on Schedule 13D originally filed with the Securities and Exchange Commission
(the Commission) on February 17, 2015, by the persons named therein and as amended by Amendments No. 1, No. 2, No. 3 and No. 4 to Schedule 13D filed with the Commission on August 18,
2015, July 15, 2016, September 16, 2016 and November 2, 2016, respectively (the Statement), is hereby amended and supplemented by this Amendment No. 5 to Schedule 13D (the
Amendment). Capitalized terms used herein and not otherwise defined have the meanings assigned to such terms in the Statement. Except as otherwise provided herein, each Item of the Statement remains unchanged. All of the
percentages calculated in this Amendment are based upon an aggregate of 87,553,024 shares of Common Stock outstanding as of February 24, 2017, as disclosed in the Companys Annual Report on Form 10-K, as filed with the Commission.

Information with respect to each Reporting Person is given solely by such Reporting Person and no Reporting Person assumes responsibility for
the accuracy or completeness of the information furnished by another Reporting Person. The Reporting Persons expressly disclaim that they have agreed to act as a group other than as described herein.

Item 4. Purpose of the Transaction.

    Item 4 of the Statement is hereby amended and supplemented by adding the following:

On March 15, 2017, the following Reporting Persons sold an aggregate of 3,024,891 shares under Rule 144 under the Securities Act:
(i) 570,710 shares by Waud Capital Partners II, L.P. (WCP II); (ii) 1,043,349 shares by Waud Capital Partners QP II, L.P. (Waud QP II); (iii) 159,233 shares by WCP FIF II (Acadia), L.P.
(WCP FIF II); (iv) 163,082 shares by Waud Capital Affiliates II, L.L.C. (Waud Affiliates II); (v) 83,694 shares by Waud Capital Affiliates III, L.L.C. (Waud Affiliates III);
(vi) 227,336 shares by WCP FIF III (Acadia), L.P. (WCP FIF III); (vii) 518,001 shares by Waud Capital Partners QP III, L.P. (Waud QP III); (viii) 91,603 shares by Waud Capital Partners III, L.P.
(WCP III); (ix) 75,000 shares by the Halcyon Exempt Family Trust (the Halcyon Trust); (x) 41,765 shares by Waud Family Partners, L.P. (WFP LP); and (xi) 51,118 by Reeve B. Waud.

Item 5. Interest in Securities of the Issuer.

    Item 5(a), (b), (c) and (e) of the Statement are hereby amended and restated in their entirety as
follows:

(a) Amount beneficially owned as of the date hereof: In the aggregate, the Reporting Persons beneficially own 4,298,733 shares of Common Stock. The shares are held of record as follows: (i) 570,710 shares by WCP II;
(ii) 1,043,348 shares by Waud QP II; (iii) 159,233 shares by WCP FIF II; (iv) 163,082 shares by Waud Affiliates II; (v) 83,694 shares by Waud Affiliates III; (vi) 227,335 shares by WCP FIF III; (vii) 518,000 shares by
Waud QP III; (viii) 91,603 shares by WCP III; (ix) 531,113 shares by the Halcyon Trust; (x) 41,765 shares by WFP LP; (xi) 4,555 shares by Reeve B. Waud; (xii) 795,667 shares by Crystal Cove LP (Crystal
Cove); (xiii) 33,333 shares by Melissa W. Waud, Mr. Wauds wife; and (xiv) 35,296 shares by Waud Capital Partners, L.L.C. (Waud Capital Partners). The 4,555 shares held of record by Mr. Waud, are
held for the benefit of Waud Capital Partners. Waud Capital Partners Management II, L.P. (WCPM II), as the general partner of WCP II, Waud QP II and WCP FIF II and the manager of Waud Affiliates II, and Waud Capital Partners II,
L.L.C. (Waud II LLC), as the general partner of WCPM II, may be deemed to share beneficial ownership of the shares of Common Stock held of record by such Reporting Persons. Waud Capital Partners Management III, L.P. (WCPM
III), as the general partner of WCP FIF III, Waud QP III and WCP III and the manager of Waud Affiliates III, and Waud Capital Partners III, L.L.C. (Waud III LLC), as the general partner of WCPM III, may be deemed to
share beneficial ownership of the shares of Common Stock held of record by such Reporting Persons. Mr. Waud may be deemed to beneficially own the shares by virtue of his (A) making decisions for the limited partner committee of each of
WCPM II and WCPM III, (B) being the manager of Waud II LLC and Waud III LLC, (C) being the general partner of WFP LP and Crystal Cove, (D) being the investment advisor of the Halcyon Trust, (E) being married to Ms. Waud and
(E) being the sole manager of Waud Capital Partners.

Percent of class: In the aggregate, the Reporting Persons
beneficially own 4,298,733 shares of Common Stock, or 4.9%, of the total number of shares of Common Stock outstanding.

(b) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: See Item 7 on the cover pages hereto.

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 21 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
21
of 26
(ii) shared power to vote or to direct the vote: See Item 8 on the cover pages hereto.
(iii) sole power to dispose or to direct the disposition of: See Item 9 on the cover pages hereto.
(iv) shared power to dispose or to direct the disposition of: See Item 10 on the cover pages hereto.
(c) See Item 4 above. The shares were sold at $41.06 per share before discounts and commissions.
(e) The Reporting Persons ceased to be the beneficial owners of more than five percent of the Common Stock on March 15, 2017 following the sale reported hereby.

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 22 of 27 – SEC Filing

SCHEDULE 13D/A

CUSIP No. 00404A109 Page
22
of 26

Item 7. Material to be Filed as Exhibits.

Exhibit A: Joint Filing Agreement dated as of July 15, 2016, by and among the Reporting Persons (previously filed as Exhibit A with the Statement filed on July 15, 2016)
Exhibit B: Amended and Restated Stockholders Agreement, dated as of October 29, 2014, by and among Acadia Healthcare Company, Inc. and the Stockholders party thereto (incorporated by reference to Exhibit 4.1 to Acadia Healthcare
Company, Inc.s Current Report on Form 8-K filed on October 30, 2014)
Exhibit C: Third Amended and Restated Registration Rights Agreement, dated as of December 31, 2015, by and among Acadia Healthcare Company, Inc. and the Parties party thereto (incorporated by reference to Exhibit 4 to Acadia Healthcare
Company, Inc.s Current Report on Form 8-K filed on January 4, 2016)
Exhibit D: Evidence of Signing Authority of Cornelius B. Waud with respect to the Halcyon Exempt Family Trust (previously filed as Exhibit E with the Statement filed on July 15, 2016)

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 23 of 27 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

Date: March 17, 2017

By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
By:

/s/ Melissa W. Waud
Name: Melissa W. Waud

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 24 of 27 – SEC Filing

WAUD CAPITAL PARTNERS II, L.P.
By: Waud Capital Partners Management II, L.P.
Its: General Partner
By: Waud Capital Partners II, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS QP II, L.P.
By: Waud Capital Partners Management II, L.P.
Its: General Partner
By: Waud Capital Partners II, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WCP FIF II (ACADIA), L.P.
By: Waud Capital Partners Management II, L.P.
Its: General Partner
By: Waud Capital Partners II, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS MANAGEMENT II, L.P.
By: Waud Capital Partners II, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS II, L.L.C.
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 25 of 27 – SEC Filing

WAUD CAPITAL PARTNERS MANAGEMENT III, L.P.
By: Waud Capital Partners III, L.LC.
Its: General Partners
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS III, L.L.C.
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS III, L.P.
By: Waud Capital Partners Management III, L.P.
Its: General Partner
By: Waud Capital Partners III, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS QP III, L.P.
By: Waud Capital Partners Management III, L.P.
Its: General Partner
By: Waud Capital Partners III, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD FIF III (ACADIA), L.P.
By: Waud Capital Partners Management III, L.P.
Its: General Partner
By: Waud Capital Partners III, L.L.C.
Its: General Partner
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 26 of 27 – SEC Filing

WAUD CAPITAL AFFILIATES II, L.L.C.
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL AFFILIATES III, L.L.C.
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD FAMILY PARTNERS, L.P.
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Authorized Signatory
WAUD CAPITAL PARTNERS, L.L.C.
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: Sole Manager
HALCYON EXEMPT FAMILY TRUST
By:

/s/ Cornelius B. Waud
Name: Cornelius B. Waud
Its: Trustee
(evidence of signing authority previously filed as Exhibit E to the Statement)
CRYSTAL COVE LP
By:

/s/ Reeve B. Waud
Name: Reeve B. Waud
Its: General Partner

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Page 27 of 27 – SEC Filing

EXHIBIT INDEX

Exhibit

Description
Exhibit A: Joint Filing Agreement dated as of July 15, 2016, by and among the Reporting Persons (previously filed as Exhibit A with the Statement filed on July 15, 2016)
Exhibit B: Amended and Restated Stockholders Agreement, dated as of October 29, 2014, by and among Acadia Healthcare Company, Inc. and the Stockholders party thereto (incorporated by reference to Exhibit 4.1 to Acadia Healthcare
Company, Inc.s Current Report on Form 8-K filed on October 30, 2014)
Exhibit C: Third Amended and Restated Registration Rights Agreement, dated as of December 31, 2015, by and among Acadia Healthcare Company, Inc. and the Parties party thereto (incorporated by reference to Exhibit 4 to Acadia Healthcare
Company, Inc.s Current Report on Form 8-K filed on January 4, 2016)
Exhibit D: Evidence of Signing Authority of Cornelius B. Waud with respect to the Halcyon Exempt Family Trust (previously filed as Exhibit E with the Statement filed on July 15, 2016)

Follow Acadia Healthcare Company Inc. (NASDAQ:ACHC)

Related Insider Monkey Articles
13D Filing: Versartis Inc. (NASDAQ:VSAR) and Sofinnova Venture Partners Viii...Phh Corp (PHH) Shares Are Way Too Cheap For Emanuel Friedman
Hyster-Yale Materials Handling Inc. (NYSE:HY): Alfred M Rankin's New FilingSunshine Heart Inc. (NASDAQ:SSH): Ki Yong Choi Files A New 13D
13D Filing: Kosloske Michael W and Health Insurance Innovations Inc. (NASDAQ...13D Filing: Icahn Capital LP and Navistar International Corp (NYSE:NAV)